Volume | 142,030 |
|
|||||
News | - | ||||||
Day High | 26.32 | Low High |
|||||
Day Low | 25.41 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Arcturus Therapeutics Holdings Inc | ARCT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
25.91 | 25.41 | 26.32 | 26.98 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
3,978 | 142,030 | $ 25.99 | $ 3,690,921 | - | 17.52 - 43.81 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:02:02 | 1 | $ 26.3674 | USD |
Arcturus Therapeutics Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
703.03M | 26.92M | - | 166.8M | -29.73M | -1.10 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Arcturus Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARCT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 27.46 | 28.80 | 25.41 | 26.65 | 428,461 | -1.18 | -4.30% |
1 Month | 33.04 | 33.99 | 25.41 | 30.23 | 490,235 | -6.76 | -20.46% |
3 Months | 33.31 | 43.81 | 25.41 | 34.73 | 495,728 | -7.03 | -21.10% |
6 Months | 19.77 | 43.81 | 17.52 | 30.55 | 454,545 | 6.51 | 32.93% |
1 Year | 28.46 | 43.81 | 17.52 | 29.71 | 432,016 | -2.18 | -7.66% |
3 Years | 36.39 | 64.9735 | 11.70 | 29.14 | 537,911 | -10.11 | -27.78% |
5 Years | 7.48 | 129.71 | 5.70 | 39.12 | 557,169 | 18.80 | 251.34% |
Arcturus Therapeutics Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19. |